ESC 365 - Prognosis of refractory shock in de-novo versus worsening Heart Failure: Insight from the HYPO-ECMO trial.

HFA Premium Access

Prognosis of refractory shock in de-novo versus worsening Heart Failure: Insight from the HYPO-ECMO trial.

Session: Acute heart failure - treatment 1

Topic: Nonpharmacological Treatment

Speaker: Doctor G. Baudry (Nancy, FR)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Guillaume Baudry

University Hospital of Brabois, Nancy (France)

2 presentations

1 follower

4 more presentations in this session

Using urine output trending for the management of acute cardio-renal syndrome in patients with acute decompensated heart failure

Speaker: Professor Y. Shacham (Tel Aviv, IL)

Continuous monitoring of advanced hemodynamic parameters during hemodialysis demonstrated early variations in patients experiencing intradialytic hypotension

Speaker: Doctor D. Nachman (Jerusalem, IL)

Cardiogenic shock in acute coronary syndrome and the use of mechanical circulatory support - is there a benefit?

Speaker: Doctor M. Figueiredo (Barreiro, PT)

Individualized recommendations for treating patients with acute kidney injury in the setting of acute heart failure by a novel strategy using causal machine learning

Speaker: Assistant Professor O. Caspi (Haifa, IL)

Access the full session

Acute heart failure - treatment 1

Speakers: Doctor G. Baudry, Professor Y. Shacham, Doctor D. Nachman, Doctor M. Figueiredo, Assistant Professor O. Caspi

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources